SS
AMPH icon

SBI Securities’s Amphastar Pharmaceuticals AMPH Stock Holding History

SBI Securities’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Buy
51
+7
+16% +$141 ﹤0.01% 2794
2026
Q1 		$862 Buy
44
+1
+2% +$24 ﹤0.01% 2713
2025
Q4 		$1.15K Buy
43
+1
+2% +$26 ﹤0.01% 2593
2025
Q3 		$1.12K Buy
42
+2
+5% +$52 ﹤0.01% 2648
2025
Q2 		$918 Hold
40
– – ﹤0.01% 2719
2025
Q1 		$1.16K Hold
40
– – ﹤0.01% 2514
2024
Q4 		$1.49K Buy
+40
New +$1.83K ﹤0.01% 2422

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SBI Securities's AMPH Position: Q2 2026 in Review

SBI Securities increased its Amphastar Pharmaceuticals (AMPH) stake by 16% in Q2 2026, buying an estimated $141 and bringing the position to 51 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

SBI Securities first reported a position in AMPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.49K in Q4 2024. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • SBI Securities held 51 shares of Amphastar Pharmaceuticals worth $1.03K as of Q2 2026.
  • SBI Securities bought 7 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $141.
  • Amphastar Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2794 holding.
  • SBI Securities first reported a position in Amphastar Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Amphastar Pharmaceuticals position peaked at $1.49K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.